Recognize
Confirm exposure/timing while excluding sepsis, hypoxia, intracranial disease, intoxication and metabolic causes.
Hyperadrenergic delirium, hallucinations or seizures after alcohol/benzodiazepine reduction.
Confirm exposure/timing while excluding sepsis, hypoxia, intracranial disease, intoxication and metabolic causes.
Provide adequate GABAergic therapy; benzodiazepines are first-line for alcohol withdrawal, with phenobarbital as an experienced-clinician option. Give thiamine and correct electrolytes.
Do not let dexmedetomidine, clonidine or antipsychotics mask undertreated withdrawal; they do not replace seizure-preventing GABAergic therapy.
Evidence status
Review metadata not yet recorded.
Status, review dates and guideline versions appear here once editorial metadata is authored for this content.
Bedside trajectory assessment, respiratory mechanics, bulbar function, airway timing, and disease-specific immunotherapy in acute neuromuscular crisis.
From 'analgesia-first' multimodal pain control and light sedation targeting to daily SAT/SBT coordination, delirium screening, and early mobility.
From acute GCS drop and herniation emergency measures to emergent CT, neurocritical intervention, and death by neurologic criteria determination.
From emergent first-line benzodiazepine administration to second-line IV non-sedating AEDs and continuous cEEG anesthetic burst suppression.
Recognition and treatment of severe withdrawal, delirium tremens and withdrawal seizures with symptom-triggered or front-loaded GABAergic therapy.
Analgesia-first sedation, light sedation targets, ABCDEF bundle, spontaneous breathing trials, and non-pharmacologic delirium mitigation.
Recognition and time-sensitive escalation of care for prolonged or repeated seizures.